Jesus' Coming Back

First Drug Proven to Reduce COVID-19 Fatalities; (Projected) US Deaths Over 200,000 By October, and Other C-Virus Updates

Researchers at the University of Oxford announced Tuesday that they had found the first proven life-saving coronavirus treatment, after a clinical trial of dexamethasone, a low-cost steroid treatment, cut the risk of death by one-third for coronavirus patients on ventilators and one-fifth for those on oxygen.

The study, part of the U.K.’s “Recovery Trial” project to find existing treatments for COVID-19, compared approximately 2,000 hospital patients that were given dexamethasone with nearly 4,000 who did not get the drug.

For patients on ventilators, it cut death risk from 40 percent to 28 percent, while patients who required oxygen saw their death risk fall from 25 percent to 20 percent.

Breaking: Oxford researchers find 1st drug proven to reduce Covid deaths

Low-cost steroid dexamethasone reduced death by a third in ventilated patients

If used from start of the pandemic it could have saved apprx 5,000 lives in UK

It costs about £5 — about £40 saves a life

pic.twitter.com/AuhXcYbjyM

— Rhys Blakely (@rhysblakely) June 16, 2020

“This is the only drug so far that has been shown to reduce mortality, and it reduces it significantly. It’s a major breakthrough,” Dr. Peter Horby, chief investigator on the study, said in a statement. Head researcher Dr. Martin Landray added that the drug’s low cost would lead to an even greater impact

. Read the rest of the story HERE and follow links below to related stories and resources:

US coronavirus deaths projected to be over 200,000 by October

First coronavirus vaccine may protect against disease, but not infection: report

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please “Like” us on Facebook either here or here. Please follow us on Twitter here.

Source

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More